CTIS.eu › Cities › France › Paris Cedex 12
Paris Cedex 12
France
153 total trials
59 recruiting
2024-515603-19-00
4
Localized digestive Neuroendocrine Carcinomas
2022-502779-40-99
5
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
2023-505200-33-00
5
Multiple myeloma
2024-513710-35-00
5
Patients presenting to ENT emergencies with a unilateral sudden sensor
2024-513801-30-00
5
Recurrent Erysipelas in lower limbs
2024-514388-24-00
4
Knee osteoarthritis
2024-514964-24-00
5
ulcerative colitis
2024-515603-19-01
4
Localized digestive Neuroendocrine Carcinomas
2024-516052-17-01
10
Patients with a diagnosis of IgAV according to Chapel Hill Consensus C
2024-516257-44-00
4
Multiple myeloma
2024-516570-30-00
4
Relapsed/refractory T-cell Acute Lymphoblastic Leukemia
2024-518139-12-00
4
locally advanced or metastatic Pancreatic ductal adenocarcinoma
2024-519753-11-00
4
Resectable borderline pancreatic adenocarcinoma
2025-520554-11-00
5
Cardiovascular Disease
2025-520976-25-00
4
Relapsed/refractory multiple myeloma
2025-524056-63-00
1
microsatellite instability high/mismatch repair deficient (MSI-H/dMMR)
2025-524573-16-00
6
Crohn's disease
2024-519870-38-00
5
2026-05-11
Atherosclerotic cardiovascular disease (ASCVD)
2025-522051-26-00
5
2026-04-23
Acquired Angioedema due to C1 Inhibitor Deficiency
2024-519496-26-00
10
2025-09-25
Intestinal Failure
2024-520209-38-00
5
2025-09-19
Obesity or Overweight
2024-517819-74-00
9
2025-06-02
Pancreatic Ductal Adenocarcinoma
2024-512119-34-00
4
2022-06-20
MSI-H/dMMR metastatic colorectal cancer
2022-500966-82-00
5
2020-03-11
Resectable locally advanced squamous cell carcinoma (SCC) of the esoph
Showing 1–24 of 153 trials